The lung is one of the organs that can be damaged in patients with thalassemia major (TM). In this study, we aimed to evaluate the pattern of lung impairment using various pulmonary tests and the effects of transfusion on pulmonary functions in patients with TM.
Materials and Methods:
The study was performed on patients 9–21 years of age prospectively. Spirometric tests, plethysmography, and CO diffusion tests were performed before and 2 h after erythrocyte transfusion. Patients also underwent a methacholine stimulation test 2 h after transfusion.
Results:
A total of 37 patients with TM were included in the study. There was no change in pretransfusion and post-transfusion spirometric test results. Plethysmographic tests revealed that both the median total lung capacity and the mean vital capacity values have decreased after transfusion. Medians of pretransfusion DLCO values significantly increased after transfusion. There was an impairment in diffusion in 16 (44.4%) patients, whereas it improved in 9 patients after transfusion. Bronchial hyperreactivity was detected in 10 out of 27 patients (37%) via methacholine stimulation test. There was obstructive airway disease in 20 patients (54%) out of 37 patients who had been tested.
Conclusions:
Patients with TM may have respiratory function abnormalities even while being asymptomatic. An obstructive airway pattern was the most common abnormality in our patient group. We revealed for the first time in the literature the presence and frequency of bronchial hypersensitivity in these patients using the methacholine stimulation test.
Get full access to this article
View all access options for this article.
References
1.
TaherAT, MusallamKM, CappelliniMD. beta-Thalassemias. N Engl J Med, 2021; 384(8):727–743.
2.
CarnelliV, D’AngeloE, PecchiariM, et al.Pulmonary dysfunction in transfusion-dependent patients with thalassemia major. Am J Respir Crit Care Med, 2003; 168(2):180–184.
3.
LandingBH, NadorraR, HymanCB, et al.Pulmonary lesions of thalassemia major. Perspect Pediatr Pathol, 1987; 11:82–96.
4.
LiAM, ChanD, LiCK, et al.Respiratory function in patients with thalassaemia major: Relation with iron overload. Arch Dis Child, 2002; 87(4):328–330.
5.
SantamariaF, VillaMP, WernerB, et al.The effect of transfusion on pulmonary function in patients with thalassemia major. Pediatr Pulmonol, 1994; 18(3):139–143.
6.
GulhanB, YalcinE, UnalS, et al.Effects of blood transfusion on cytokine profile and pulmonary function in patients with thalassemia major. Clinical Respiratory J, 2016; 10(2):153–162.
7.
KanjN, ShamseddineA, GharzeddineW, et al.Relation of ferritin levels to pulmonary function in patients with thalassemia major and the acute effects of transfusion. Eur J Haematol, 2000; 64(6):396–400.
8.
OzyorukD, MisirliogluED. Pulmonary functions in children with thalassemia major. J Pediatr Hematol Oncol, 2015; 37(8):605–610.
9.
ImaiT, TakaseM, TakedaS, et al.Serum KL-6 levels in pediatric patients: Reference values for children and levels in pneumonia, asthma, and measles patients. Pediatr Pulmonol, 2002; 33(2):135–141.
10.
CarpenterJP, HeT, KirkP, et al.On T2* magnetic resonance and cardiac iron. Circulation, 2011; 123(14):1519–1528.
11.
CastellsagueJ, BurgosF, SunyerJ, et al.Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey. Respir Med, 1998; 92(3):401–407.
12.
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med, 1995; 152(3):1107–1136.
13.
American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique–1995 update. Am J Respir Crit Care Med, 1995; 152(6 Pt 1):2185–2198.
14.
CrapoRO, CasaburiR, CoatesAL, et al.Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med, 2000; 161(1):309–329.
15.
ParakhA, DubeyAP, ChowdhuryV, et al.Study of pulmonary function tests in thalassemic children. J Pediatr Hematol Oncol, 2007; 29(3):151–155.
16.
PiattiG, AllegraL, AmbrosettiU, et al.Beta-thalassemia and pulmonary function. Haematologica, 1999; 84(9):804–808.
17.
Abd El HakeemAA, MousaSMO, AbdelFattahMT, et al.Pulmonary functions in Egyptian children with transfusion-dependent beta-thalassemia. Transfus Med, 2019; 29(1):55–60.
18.
BourliE, DimitriadouM, EconomouM, et al.Restrictive pulmonary dysfunction and its predictors in young patients with beta-thalassaemia major. Pediatr Pulmonol, 2012; 47(8):801–807.
19.
PiattiG, AllegraL, FasanoV, et al.Lung function in beta-thalassemia patients: A longitudinal study. Acta Haematol, 2006; 116(1):25–29.
20.
Abu-EkteishFM, Al-RimawiHS, Al-AliMK, et al.Pulmonary function tests in children with beta-thalassemia major. Chron Respir Dis, 2007; 4(1):19–22.
21.
ChanKC, AuCT, LeungAWK, et al.Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload. Sci Rep, 2023; 13(1):3674.
22.
ErsoyGZ, NainE, ErtekinM, et al.Restrictive effects of thalassemia on respiratory functions: One center experience. North Clin Istanb, 2023; 10(5):589–596.
23.
SohnEY, NoetzliLJ, GeraA, et al.Pulmonary function in thalassaemia major and its correlation with body iron stores. Br J Haematol, 2011; 155(1):102–105.
24.
CooperDM, MansellAL, WeinerMA, et al.Low lung capacity and hypoxemia in children with thalassemia major. Am Rev Respir Dis, 1980; 121(4):639–646.
25.
FactorJM, PottipatiSR, RappoportI, et al.Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med, 1994; 149(6):1570–1574.
26.
GrisaruD, RachmilewitzEA, MosseriM, et al.Cardiopulmonary assessment in beta-thalassemia major. Chest, 1990; 98(5):1138–1142.
27.
HoytRW, ScarpaN, WilmottRW, et al.Pulmonary function abnormalities in homozygous beta-thalassemia. J Pediatr, 1986; 109(3):452–455.
28.
KeensTG, O’NealMH, OrtegaJA, et al.Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program. Pediatrics, 1980; 65(5):1013–1017.
29.
KhongPL, ChanGC, LeeSL, et al.Beta-thalassemia major: Thin-section CT features and correlation with pulmonary function and iron overload. Radiology, 2003; 229(2):507–512.
30.
GrantGP, MansellAL, GrazianoJH, et al.The effect of transfusion on lung capacity, diffusing capacity, and arterial oxygen saturation in patients with thalassemia major. Pediatr Res, 1986; 20(1):20–23.
31.
AroraM, ChandraJ, SuriJC, et al.Pulmonary function tests in beta thalassemia. Indian J Pediatr, 2001; 68(3):239–242.
32.
FreedmanMH, GrisaruD, OlivieriN, et al.Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions. Am J Dis Child, 1990; 144(5):565–569.
33.
Golan-LagzielT, MandelbergA, WolfsonY, et al.Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma? Pediatr Pulmonol, 2021; 56(10):3200–3208.
34.
OzbekOY, MalboraB, SenN, et al.Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatr Pulmonol, 2007; 42(12):1187–1192.
35.
HazirolanT, EldemG, UnalS, et al.Dual-echo TFE MRI for the assessment of myocardial iron overload in beta-thalassemia major patients. Diagn Interv Radiol, 2010; 16(1):59–62.
36.
DavidsenES, LisethK, OmvikP, et al.Reduced exercise capacity in genetic haemochromatosis. Eur J Cardiovasc Prev Rehabil, 2007; 14(3):470–475.
37.
ShizukudaY, TripodiDJ, RosingDR. Iron overload or oxidative stress? Insight into a mechanism of early cardiac manifestations of asymptomatic hereditary hemochromatosis subjects with C282Y Homozygosity. J Cardiovasc Transl Res, 2016; 9(4):400–401.
